[1] Langtry HD, Brogden RN. Clarithromycin: A review of its efficacy in the treatment of respiratory tract infections in immuocompetent patients [J]. Drugs, 1997, 53 (6): 973-1004. [2] Rodvold KA. Clinical pharmacokinetics of clarithromycin [J]. Clin Pharmacokinet, 1999, 37 (5): 385-398. [3] Fernandes PB, Ramer N, Rode RA, et al. Bioassay for A-56268 (TE-031) and identification of its major metabolite 14-hydroxy-6-O-mythyl erythromycin [J]. Eur J Clin Microbiol Infect Dis, 1988, 7: 73-76. [4] Chu SY, Wilson, DS, Guay DRP, et al. Clarithromycin pharmacokinetics in healthy young and elderly volunteers [J]. J Clin Pharmacol, 1992, 32: 1045-1049. [5] Hedenmo M, Eriksson BM. Liquid chromatographic determination of the macrolide antibiotics roxithromycin and clarithromycin in plasma by automated solid-phase extraction and electrochemical detection [J]. J Chromatogr A, 1995, 692: 161-166. [6] Kees F, Spangler S, Wellenhofer M. Determination of macrolides in biological matrices by high-performance liquid chromatography with electrochemical detection [J]. J Chromatogr A, 1998, 812: 287-293. [7] Tononaka C, Ohtani H, Hanada E, et al. Determination of erythromycin, clarithromycin, roxithromycin, and azithromycin in plasma by high-performance liquid chromatography with amperometric detection [J]. J Chromatogr B, 2000, 738: 405-411. [8] Niopas I, Daftsios AC. Determination of clarithromycin in human plasma by HPLC with electrochemical detection: validation and application in pharmacokinetic study [J]. Biomed Chromatogr, 2001, 15: 507-508. [9] Wibawa J ID, Shaw PN, Barrett DA. Quantification of clarithromycin, its 14-hydroxy and decladinose metabolite in rat plasma, gastric juice and gastric tissue using high-performance liquid chromatography with electrochemical detection [J]. J Chromatogr B, 2003, 783: 359-366. [10] Van Rooyen GF, Smit MJ, De Jager AD. Sensitive liquid chromatography-tandem mass spectrometry method for the determination of clarithromycin in human plasma [J]. J Chromatogr B, 2002, 768: 223-229. [11] Shah VP, Midha KK, Findlay JW. Bioanalytical method validationa revisit with a decade of progress [J]. Pharm Res, 2000, 17: 1551-1557. [12] Yasuo N, Shigeru I, Tsuguchika Y, et al. Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparision with erythromycin [J]. Chem Pharm Bull, 1992, 40: 725-728. [13] Grübel P, Cave DR. Factors affecting solubility and penetration of clarithromycin through gastric mucus [J]. Aliment Pharmacol Ther, 1998, 12: 569-576. |